Schedule 13D ownership disclosure
ANIKA THERAPEUTICS INC
Security class unavailable · CUSIP: 035255108
Event date: 2024-03-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-24-002242
- Form type
- SC 13D
- Filer
- Anika Therapeutics, Inc.
- CIK
- CIK 898437
- Filed
- Mar 06, 2024
- Reporting period
- Mar 04, 2024
- Description
- Schedule 13D beneficial ownership